OptimizeRx
OPRX
40 hedge funds and large institutions have $57.4M invested in OptimizeRx in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 7 closing their positions.
122% more capital inflows, than outflows
Capital inflows: $8.29M | Capital outflows: $3.73M
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
5% more funds holding
Funds holding: 38 → 40 (+2)
2.44% more ownership
Funds ownership: 34.86% → 37.3% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Taylor Wealth Management Partners
Boston,
Massachusetts
|
+$1.32M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.25M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$828K |
| 4 |
Millennium Management
New York
|
+$591K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$488K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wasatch Advisors
Salt Lake City,
Utah
|
-$866K |
| 2 |
EAM Investors
Solana Beach,
California
|
-$781K |
| 3 |
Oxford Asset Management
Oxford,
United Kingdom
|
-$332K |
| 4 |
Venator Capital Management
Toronto,
Ontario, Canada
|
-$252K |
| 5 |
G2 Investment Partners Management
New York
|
-$234K |
OPRX Hedge Fund Activity: Q1 2019 in Review
40 of the 4,634 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2019, worth a combined $57.4M — up 25% from $45.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new OPRX positions and 7 closed out — a net gain of 2 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Taylor Wealth Management Partners, opening a new position worth an estimated $1.32M. The largest seller was Wasatch Advisors, cutting an estimated $866K.
- 40 institutional investors held OptimizeRx (OPRX) as of Q1 2019, up from 38 in Q4 2018.
- Funds reported $57.4M of OptimizeRx stock for Q1 2019, up 25% quarter-over-quarter.
- 9 funds opened new OptimizeRx positions in Q1 2019 and 7 closed out, a net change of +2 holders.
- The largest OptimizeRx buyer in Q1 2019 was Taylor Wealth Management Partners, an estimated $1.32M added.
- The largest OptimizeRx seller in Q1 2019 was Wasatch Advisors, an estimated $866K sold.
Based on aggregated 13F filings for Q1 2019.